Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2669880317;80318;80319 chr2:178566040;178566039;178566038chr2:179430767;179430766;179430765
N2AB2505775394;75395;75396 chr2:178566040;178566039;178566038chr2:179430767;179430766;179430765
N2A2413072613;72614;72615 chr2:178566040;178566039;178566038chr2:179430767;179430766;179430765
N2B1763353122;53123;53124 chr2:178566040;178566039;178566038chr2:179430767;179430766;179430765
Novex-11775853497;53498;53499 chr2:178566040;178566039;178566038chr2:179430767;179430766;179430765
Novex-21782553698;53699;53700 chr2:178566040;178566039;178566038chr2:179430767;179430766;179430765
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: D
  • RefSeq wild type transcript codon: GAT
  • RefSeq wild type template codon: CTA
  • Domain: Fn3-82
  • Domain position: 16
  • Structural Position: 18
  • Q(SASA): 0.3301
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
D/V rs368085497 0.305 0.994 N 0.591 0.499 None gnomAD-2.1.1 8.05E-06 None None None None N None 6.46E-05 0 None 0 0 None 0 None 0 8.9E-06 0
D/V rs368085497 0.305 0.994 N 0.591 0.499 None gnomAD-4.0.0 1.36866E-05 None None None None N None 2.99007E-05 0 None 0 0 None 0 0 1.70925E-05 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
D/A 0.2709 likely_benign 0.299 benign -0.195 Destabilizing 0.961 D 0.487 neutral N 0.471991122 None None N
D/C 0.6898 likely_pathogenic 0.6909 pathogenic -0.062 Destabilizing 1.0 D 0.675 prob.neutral None None None None N
D/E 0.1739 likely_benign 0.1971 benign -0.775 Destabilizing 0.122 N 0.102 neutral N 0.459588001 None None N
D/F 0.6461 likely_pathogenic 0.6566 pathogenic -0.457 Destabilizing 0.999 D 0.611 neutral None None None None N
D/G 0.1767 likely_benign 0.1817 benign -0.477 Destabilizing 0.961 D 0.441 neutral N 0.498549034 None None N
D/H 0.3893 ambiguous 0.4288 ambiguous -0.936 Destabilizing 0.994 D 0.481 neutral D 0.523138047 None None N
D/I 0.5106 ambiguous 0.5412 ambiguous 0.515 Stabilizing 0.999 D 0.597 neutral None None None None N
D/K 0.5854 likely_pathogenic 0.6318 pathogenic -0.375 Destabilizing 0.97 D 0.433 neutral None None None None N
D/L 0.545 ambiguous 0.5759 pathogenic 0.515 Stabilizing 0.996 D 0.593 neutral None None None None N
D/M 0.6581 likely_pathogenic 0.6942 pathogenic 0.937 Stabilizing 1.0 D 0.606 neutral None None None None N
D/N 0.1011 likely_benign 0.1059 benign -0.534 Destabilizing 0.248 N 0.264 neutral N 0.472322438 None None N
D/P 0.9198 likely_pathogenic 0.9304 pathogenic 0.304 Stabilizing 0.999 D 0.465 neutral None None None None N
D/Q 0.4274 ambiguous 0.4818 ambiguous -0.454 Destabilizing 0.991 D 0.444 neutral None None None None N
D/R 0.6338 likely_pathogenic 0.6783 pathogenic -0.446 Destabilizing 0.991 D 0.504 neutral None None None None N
D/S 0.1556 likely_benign 0.1675 benign -0.759 Destabilizing 0.97 D 0.436 neutral None None None None N
D/T 0.2489 likely_benign 0.2669 benign -0.543 Destabilizing 0.97 D 0.459 neutral None None None None N
D/V 0.3472 ambiguous 0.3693 ambiguous 0.304 Stabilizing 0.994 D 0.591 neutral N 0.498742658 None None N
D/W 0.918 likely_pathogenic 0.9214 pathogenic -0.557 Destabilizing 1.0 D 0.662 neutral None None None None N
D/Y 0.3084 likely_benign 0.3102 benign -0.298 Destabilizing 0.998 D 0.611 neutral N 0.516593423 None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.